Cause of death in MS: long-term follow-up of a randomised cohort, 21 years after the start of the pivotal IFNβ-1b study

OBJECTIVES: Compared with controls, multiple sclerosis (MS) patients die, on average, 7–14 years prematurely. Previously, we reported that, 21 years after their participation in the pivotal randomised, controlled trial (RCT) of interferon β-1b, mortality was reduced by 46–47% in the two groups who r...

Descripción completa

Detalles Bibliográficos
Autores principales: Goodin, Douglas S, Ebers, George C, Cutter, Gary, Cook, Stuart D, O'Donnell, Timothy, Reder, Anthony T, Kremenchutzky, Marcelo, Oger, Joel, Rametta, Mark, Beckmann, Karola, Knappertz, Volker
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2012
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533062/
https://www.ncbi.nlm.nih.gov/pubmed/23204140
http://dx.doi.org/10.1136/bmjopen-2012-001972

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533062/
https://www.ncbi.nlm.nih.gov/pubmed/23204140
http://dx.doi.org/10.1136/bmjopen-2012-001972

Ejemplares similares